Skip to content

Upcoming tradeshows and conferences 

PDA

Oct 21 - Oct 22, 2025
Vienna, Austria
Hall X2, #150

PODD

Oct 27 -Oct 29, 2025
Boston, MA, USA
#26

CPHI

Oct 28 - Oct 30, 2025
Frankfurt, Germany
Hall 8, #0J92

Don’t miss our presentations at PODD and CPHI!

  • PODD
    • Monday, October 27, 2025 – 05:30 PM - 05:45 PM
      A Novel Approach to Modelling Injector Performance and Break-Loose Extrusion Force Data
      Presenter: Tom Oakley, Springboard, co-presenting with Deep Bhattacharya, Pfizer
  • CPHI
    • Wednesday, October 29, 2025 – 11:35 AM - 12:05 PM
      Rethinking Injector Mechanics – A New Approach to BLEF-Based Modelling
      Speakers: Tom Oakley, Springboard, co-presenting with Jay Sayed, Pfizer
    • Wednesday, October 29, 2025 – 12:05 PM - 12:20 PM
      Modelling to Market – Enabling Smarter, Faster Injector Development
      Speaker: Alex Vasiev, Springboard

Meet our experts at the conferences

Feel free to reach out to our sales representatives to arrange a meeting in advance.
Click on the images to send an email.

Christian Classen-1

Christian Classen
Chief Sales Officer, CSO
PDA, CPHI

Tom Oakley

Tom Oakley
VP Strategic Design & Development Partnerships (Europe)
PODD, CPHI

01-geoff-jones2

Geoff Jones
Vice President Sales, CDMO
PDA, CPHI

Ed Butler

Ed Butler
Business Development Manager
PDA, PODD

03-chuck-crandley

Chuck Crandley
Business Development Manager
PODD

Sven Dasbach

Sven Dasbach
Business Development Manager
CPHI

Paula Dominguez

Paula Domínguez
Business Development Manager
CPHI

Joe Masci

Joe Masci
Business Development Manager
PODD

Cameron Palagruto

Cameron Palagruto
Business Development Manager
PODD

Alex Vasiev

Alex Vasiev
Business Development Manager
CPHI

  

Design and Develop your Next Clinical Respiratory Device with Sanner

Sanner combines sustainable design, scientific principles and years' of experience designing and delivering respiration drug delivery devices for clients. 

Custom Clinical Devices for Respiratory Applications

Develop your next clinical or commercial inhalation device with a team of experts from Sanner. We have experience across a wide range of form factors and delivery methods, from pressurized metered dose inhalers to soft mist inhalers and complex electronic devices.

Find out how more about our expertise and how we have helped clients in the industry.

Frame 4175-1
Group
Pressurized Metered Dose Inhalers (pMDIs)
2-2
Dry Powder Inhalers
(DPIs)
3
Soft Mist Inhalers
(SMIs)
Layer_1
Respiratory Diagnostic Devices

Adobe-screens-on-watch

How We Drive Your Product from Paper to Production

Frame 4176

Advanced Modeling Experience

 Computational fluid dynamics simulation allows us to model airflow, particle deposition, and spray dynamics with precision before prototyping begins. 

Frame 4177

Design for Manufacture & Assembly

Our DFMA process aligns functional design intent with scalable production, ensuring consistent device performance from pilot batches through full commercial volumes. 

Frame 4178

Electromechanical Medical Device Expertise

 Today's respiratory devices rely on precise electronics and embedded software to drive delivery mechanisms, monitor performance, and support diagnostic functions. 

 
 
 
 

Sanner Accelerates Development for Clinical Respiratory Devices

Design & Development

  • Human Factors

  • Industrial Design

  • Device Engineering

  • Electronics and Software

  • Regulatory Services

Scalable Manufacturing

  • Design for Manufacture

  • Cleanroom Injection Molding

  • Class 7 & 8 Cleanrooms

  • Small Batch and Clinical Builds

  • Commercialization

Insights from Sanner

Sanner Inhaler mit Mundstück_print-3

Manufacturing medical devices for use in clinical trials

Clinical trials are an inherent step in the development process for a device. However, manufacturing devices for clinical trials can be a challenge. Find out how we helped PulmoBioMed with their device development and manufacture.

 

logo-20

Delivering and maintaining optimal DPI performance

In this whitepaper, Chris Gilmor looks into the demand and device development challenges for DPI's including how to handle moisture. He looks into how to maintain performance without compromising the formulation and tackles environmental moisture challenges for the devices. 

Rectangle 490
A happy baby after a vaccine

Developing a Simpler Nasal Vaccine Administration Device for Infants

The quicker a vaccine is administered to infants, the better, for the parents and patients alike.

A leading vaccine supplier approached Sanner to design and develop a device that enabled faster nasal administration for their vaccine, reducing user steps, to get the right dose for the child.

Shielded Therapeutics: Could Polymeric Nanoparticles Safeguard Inhaled Drugs?

Polymeric nanoparticles (PNPs) represent a groundbreaking advancement at the cutting edge of pulmonary drug delivery, holding great promise for overcoming the key challenges in respiratory medicine. 

Find out some key finding in this field and the opportunities and challenges that come with it.

Figure 1 lung diagram v2

Worldwide production capacity and device development services

Sanner operates a global manufacturing network with a total production space of 28,500 sqm, including 11,000 sqm of cleanroom space (Class 7/8). Our Design Centers of Excellence, Springboard and Gilero, are strategically located in the UK and across the US. Our manufacturing facilities are based in the US, Asia and Europe.

Sanner locations

 
How we can help you

  • Capacity for small-batch prototypes and scaling to full production. Our facilities are equipped to handle a wide range of production needs:
    • High precision fully electric thermoplastic injection molding capable of handling small shot weights (around 0.1g) up to 64-cavity molds (max. 350T), including 2K molding with thermoplastic elastomers (TPE). 
    • Manual assembly up to fully automated assembly processes, incorporating mechatronic components for enhanced efficiency and precision.
    • End of line packaging for sub-assemblies or finished goods
    • Sterilization through trusted external partners, utilizing validated processes to ensure compliance with industry standards.
  • Our experience in successfully transferring innovations to production across the EU, US, and China speaks to our ability to bring cutting-edge technologies to global markets. All phases of device development can be supported from our Design and Development Centers of Excellence in both the US and EU. 
  • Our design transfer processes enable the smoother path to market. We offer end-to-end thinking from development to manufacturing all under one roof to de-risk your project and for a better time to market.
  • Our reliability and collaborative working attitude support you in any stage of your project.

 

Quality control processes and compliance with ISO 13485

Sanner Group facilities are ISO 13485 certified for Design & Development and Manufacturing respectively. Over 250 ISO, AAMI/ANSI standards are used routinely. Our streamlined quality system satisfies the FDA requirements for both the device quality system regulations and the part 210/211 cGMP regulations.

 

Talk to an expert
Talk to us today about your next device development project.